Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 329 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR First-Line Treatment with Ribociclib plus Letrozole Shows a Significant Overall Survival... March 22, 2022 County Denies Immunocompromised Employee’s Request to Work from Home During COVID-19 March 17, 2020 2021 ASCO Annual Meeting Research Round Up: Advances in Treating Brain... September 30, 2021 ‘Inside Edition’ Anchor Thanks Viewer For Pointing Out Lump That Turned... April 24, 2019 Load more HOT NEWS Enfortumab Vedotin Approved for Recurrent Bladder Cancer RNF43 Mutations Warrant Further Validation for Potential to Prioritise Anti-EGFR/BRAF Combinations... Rare Disease Day: Raising Awareness for Rare Cancers News digest – sponge on a string, junk food watershed, prostate...
